Bertis Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 59

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 16

Bertis General Information

Description

Developer of a proteomics technology platform designed for early disease detection. The company's platform integrates mass spectrometry with artificial intelligence and machine learning algorithms to identify protein biomarkers from blood samples, enabling healthcare providers to detect early-stage cancers and access personalized treatment data.

Contact Information

Website
www.bertis.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Rooms 301, 302, Building B, D-Tech Tower, 33
  • Gwacheon-daero 7-gil
  • Gwacheon, Gyeonggi
  • South Korea
Primary Industry
Diagnostic Equipment
Other Industries
Discovery Tools (Healthcare)
Laboratory Services (Healthcare)
Biotechnology
Vertical(s)
Artificial Intelligence & Machine Learning, Life Sciences, Oncology
Corporate Office
  • Rooms 301, 302, Building B, D-Tech Tower, 33
  • Gwacheon-daero 7-gil
  • Gwacheon, Gyeonggi
  • South Korea

Bertis Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bertis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 01-Jan-2025 Completed Generating Revenue
3. Later Stage VC 26-Jan-2024 Completed Generating Revenue
2. Later Stage VC 28-Dec-2020 $14.6M $23.9M Completed Generating Revenue
1. Seed Round 31-Oct-2018 $9.3M $9.3M Completed Generating Revenue
To view Bertis’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Bertis Patents

  • 51

    Total Documents Applications and Grants

  • Total Patents Families

  • 13

    Granted

  • 17

    Pending

  • Expiring in next 12 mo

Bertis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024440544-A1 Novel biomarker for diagnosing pancreatic cancer Pending 22-May-2024
WO-2025244187-A1 Novel biomarker for diagnosing pancreatic cancer Pending 22-May-2024
US-20250362300-A1 Novel biomarkers for diagnosing pancreatic cancer Pending 22-May-2024
WO-2025230318-A1 Biomarker for determining subtype of triple-negative breast cancer and use thereof Pending 30-Apr-2024
WO-2025221034-A1 Composition for detecting analyte Pending 17-Apr-2024 G01N33/6848
To view Bertis’s complete patent history, request access »

Bertis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bertis Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
Loftyrock Investment Venture Capital Minority
Dream CIS Corporation Minority
Korea Development Bank VC-Backed Company Minority
Pathway Partners (Korea) Venture Capital Minority
Samsung Venture Investment Corporate Venture Capital Minority
You’re viewing 5 of 16 investors. Get the full list »

Bertis Investments (1)

Bertis’s most recent deal was a Seed Round with DCGen. The deal was made on 30-Sep-2018.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
DCGen 30-Sep-2018 Seed Round Diagnostic Equipment
To view Bertis’s complete investments history, request access »

Ready to get started?

Request a free trial

Bertis FAQs

  • When was Bertis founded?

    Bertis was founded in 2014.

  • Where is Bertis headquartered?

    Bertis is headquartered in Gwacheon, South Korea.

  • What is the size of Bertis?

    Bertis has 59 total employees.

  • What industry is Bertis in?

    Bertis’s primary industry is Diagnostic Equipment.

  • Is Bertis a private or public company?

    Bertis is a Private company.

  • What is Bertis’s current revenue?

    The current revenue for Bertis is .

  • How much funding has Bertis raised over time?

    Bertis has raised $39.1M.

  • Who are Bertis’s investors?

    Loftyrock Investment, Dream CIS, Korea Development Bank, Pathway Partners (Korea), and Samsung Venture Investment are 5 of 16 investors who have invested in Bertis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process